Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation

Propylthiouracil (PTU) is a common drug used in patients with hyperthyroidism. It may cause perinuclearantineutrophil cytoplasmic antibodies (p-ANCA) in few patients with Graves’ disease. This antibody has been associated with different forms of vasculitis. We report a patient who presented with cut...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayturk, Semra, Demir, Mustafa Volkan, Yaylacı, Selçuk, Tamer, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683219/
https://www.ncbi.nlm.nih.gov/pubmed/23776917
http://dx.doi.org/10.4103/2230-8210.109665
_version_ 1782273474308341760
author Ayturk, Semra
Demir, Mustafa Volkan
Yaylacı, Selçuk
Tamer, Ali
author_facet Ayturk, Semra
Demir, Mustafa Volkan
Yaylacı, Selçuk
Tamer, Ali
author_sort Ayturk, Semra
collection PubMed
description Propylthiouracil (PTU) is a common drug used in patients with hyperthyroidism. It may cause perinuclearantineutrophil cytoplasmic antibodies (p-ANCA) in few patients with Graves’ disease. This antibody has been associated with different forms of vasculitis. We report a patient who presented with cutaneous manifestations of leukocytoclasticvasculitis with simultaneous development of p-ANCAs during PTU therapy for Graves’ disease.
format Online
Article
Text
id pubmed-3683219
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36832192013-06-17 Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation Ayturk, Semra Demir, Mustafa Volkan Yaylacı, Selçuk Tamer, Ali Indian J Endocrinol Metab Case Report Propylthiouracil (PTU) is a common drug used in patients with hyperthyroidism. It may cause perinuclearantineutrophil cytoplasmic antibodies (p-ANCA) in few patients with Graves’ disease. This antibody has been associated with different forms of vasculitis. We report a patient who presented with cutaneous manifestations of leukocytoclasticvasculitis with simultaneous development of p-ANCAs during PTU therapy for Graves’ disease. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3683219/ /pubmed/23776917 http://dx.doi.org/10.4103/2230-8210.109665 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ayturk, Semra
Demir, Mustafa Volkan
Yaylacı, Selçuk
Tamer, Ali
Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title_full Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title_fullStr Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title_full_unstemmed Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title_short Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation
title_sort propylthiouracil induced leukocytoclastic vasculitis: a rare manifestation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683219/
https://www.ncbi.nlm.nih.gov/pubmed/23776917
http://dx.doi.org/10.4103/2230-8210.109665
work_keys_str_mv AT ayturksemra propylthiouracilinducedleukocytoclasticvasculitisararemanifestation
AT demirmustafavolkan propylthiouracilinducedleukocytoclasticvasculitisararemanifestation
AT yaylacıselcuk propylthiouracilinducedleukocytoclasticvasculitisararemanifestation
AT tamerali propylthiouracilinducedleukocytoclasticvasculitisararemanifestation

Ejemplares similares